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Introduction: The statistics show that the numbers of cancer reports is increasing 
and need for development of new anticancer drugs is a principal aim in current 
medicinal chemistry. Due to very limitations of current antineoplastic therapeutics 
such as high incidence of adverse effects and intuitive resistance of tumor, discovery 
of new anticancer agents feel to be crucial.  
Methods and Results: Synthesis and cytotoxicity assessment of 1,3,4-thiadiazole 
derivatives led to the discovery of new compounds with potential anticancer activity. 
MTT assay was done against three cancerous cell lines containing PC3 (prostate 
carcinoma), HT-29 (human colon adenocarcinoma) and SKNMC(neuroblastoma) in 
comparison with doxorubicin as reference drug. All synthesized compounds were 
identified using spectroscopic techniques like 
1
HNMR, IR and MS. The synthesized 
derivatives were afforded with high yields. All target compounds were tested against 
MCF-7 (breast cancer), H1299 (non-small cell lung carcinoma), A2780 (ovarian 
carcinoma). Tested derivatives exhibited favorable anticancer activity in vitro 
compared to doxorubicin in MTT assay. Various derivatives such as Cl, Br, CH3 and 
F substituents were the best moieties for para positions of the phenyl ring (less than 
1 µM). Some of tested compounds with these moieties showed superior activity than 
doxorubicin. Caspases activation was also explored for tested derivatives. 
Conclusions: The 1,3,4-thiadiazole derivatives that prepared in the current project 
displayed significant anticancer activity and apoptosis induction. These agents could 
be proposed as novel anticancer lead compounds. 
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